TABLE 3.
Analysis of lipid profile in the two study groups.
| Character | Group (1) control group (n = 27) | Group (2) atorvastatin group (n = 26) | b p-value | ||||
|---|---|---|---|---|---|---|---|
| Before treatment | After treatment | a p-value | Before treatment | After treatment | a p-value | After treatment | |
| TC (mg/dL) | 162.8 ± 16.94 | 164.7 ± 14.17 | 0.276 (t = 1.111, df = 26) | 163.1 ± 17 | 156.3 ± 14.43 | 0.0003 (t = 4.161, df = 25) | 0.037 (t = 2.137, df = 51) |
| TG (mg/dL) | 135.1 ± 15.34 | 132.3 ± 10.28 | 0.311 (t = 1.033, df = 26) | 128.3 ± 12.2 | 124.8 ± 13.87 | 0.013 (t = 2.670, df = 25) | 0.030 (t = 2.227, df = 51) |
| HDL (mg/dL) | 45.19 ± 8.13 | 43.85 ± 6.65 | 0.110 (t = 1.651, df = 26) | 45.23 ± 8.83 | 48.42 ± 7.19 | 0.0004 (t = 4.049, df = 25) | 0.019 (t = 2.403, df = 51) |
| LDL (mg/dL) | 90.61 ± 17.78 | 94.43 ± 14.87 | 0.069 (t = 1.896, df = 26) | 92.88 ± 18.74 | 82.95 ± 14.84 | >0.0001 (t = 5.164, df = 25) | 0.007 (t = 2.812, df = 51) |
Data are expressed as mean ± SD, Significance at (p < 0.05). Total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), (a) within group comparison, (b) between group comparison.